Kinship Circle
Action List
spacer
Action Alerts  |  Email List  |  Fact Sheets  |  Store  |  About Us  |  Updates  |  Victories  |  Your Alerts  |  Linksspacer
spacerDisaster Aid  |  Donate  |  Volunteer  |  Columns & Articles  |  Ad Designs  |  Stanley  |  Mission  |  Home
spacer spacer

8/4/09: Target - HLS Top Customers AstraZeneca & GlaxoSmithKline

spacer
spacer
spacer
spacer SOURCE OF INFORMATION / BACKGROUND
spacer
spacer
Share/Bookmark
spacer
UPDATE - 7/19/09: No Money = No Huntingdon Life Sciences
SOURCE: HLS FINANCIAL POSITION

7/19/09, SUMMARY: The pressure on customers of Huntingdon Life Sciences seems to be working. Within the last 12 months, HLS loses two major customer contracts. Their share price plummets by 75%, from just under $40 to around $8. This drop is due, in part, to global campaigning against Huntingdon’s shareholder base and customers.

HLS also loses their top 5 shareholders over 4 months: Barclays, Bank of New York, Mellon and Highbridge Capital. HLS (LSR) are still $72 million in debt and their first published accounts this year show a revenue decrease of 24%. With no directors taking bonuses last year, Brian Cass has cut jobs at UK labs and has said the future for HLS looks "uncertain." Borrowed money must be repaid by 2011 — but the floundering lab needs to secure a loan to do so and currently can't get one. Ultimately, Huntingdon Life Sciences need a $60 million loan to pay off debts. But they could go bankrupt first, if they lose another customer.

• 2006 - 2008: See More Financiers / Customers / Suppliers That Dumped Huntingdon Life Sciences



•  HLS Top Targets
•  ADI report and 2008 video footage shot inside HLS
•  Save The Primates, Documentary from ADI and NAVS
•  HUNTINGDON LIFE SCIENCES EXPOSED
•  All Global HLS Targets
•  Campaign to close Huntingdon Life Sciences
•  INSIDE-OUT / DIARY OF MADNESS




THIS IS HUNTINGDON LIFE SCIENCES. Seven undercover investigations over 12 years have exposed such abuse as HLS technicians who push naso-gastric tubes into dogs' lungs, drowning animals in toxic materials meant for their stomachs. In one video clip, a technician repeatedly punches a screaming 4-month-old beagle in the face. During a supposedly post-mortem dissection, another tech slices into the chest of a convulsing monkey... Animals seen dangling from slings or cowering in cages are left to seize, vomit and collapse with no vet care.

SERVING SCIENCE? "The best guess for the correlation of adverse reactions in man and animal toxicity data is somewhere between 5% and 25%" — Animal Toxicity Studies: Their Relevance to Man, Lumley and Walker (eds) (Quay, 1989), 57-67
spacer
spacer
spacerEMAIL A LETTER (1st 2 buttons) - OR - FAX / MAIL A LETTER (2nd 2 buttons)
spacer
spacer
           

 ** 


EMAIL LETTER: If you don't have email software on your computer, an error message occurs.
In this case, send the letter from your web mail:
COPY all email addresses and the sample letter to PASTE into the appropriate text fields.

Back to top

spacer
spacerSAMPLE LETTER + CONTACT INFORMATION
spacer
spacer
CONTACT INFORMATION • SEND THIS LETTER

AstraZeneca
• David Brennan, Chief Executive Officer:
david.brennan@astrazeneca.com
• Simon Lowth, Chief Financial Officer:
simon.lowth@astrazeneca.com
• Tony Zook, Executive Vice President North America:
tony.zook@AstraZeneca.com
• Bruno Angelici, Exec. Vice President, Europe and ROW:
bruno.angelici@AstraZeneca.com
• David Smith, Executive Vice-President, Operations:
david.smith@AstraZeneca.com
• Jan Lundberg, Exec. Vice-President Discovery Research:
jan.lundberg@AstraZeneca.com
• Lynn Tetrault, Exec. Vice-President Human Resources:
lynn.tetrault@AstraZeneca.com
• Senior Non-Executive Director:
peter.bonfield@AstraZeneca.com

ASTRAZENECA WORLDWIDE LOCATIONS-ADDRESSES
www.astrazeneca.com/about-us/addresses/

AstraZeneca Pharmaceuticals LP (U.S. Headquarters)
P.O. Box 15437
Wilmington, DE 19850-5437
ph: +1 302 886 3000, +1 302 886 2972
website: www.astrazeneca-us.com
CONTACT INFORMATION FROM: info@shac.net,
GlaxoSmithKline
• Andrew Witty, CEO, Board of Directors:
Andrew.Witty@gsk.com
• Julian Heslop, Chief Financial Officer, Board of Directors:
Julian.Heslop@gsk.com
• Moncef Slaoui, Chairman of Research & Development,
Board of Directors: Moncef.Slaoui@gsk.com
• David Pulman, President of Global Manufacturing
and Supply: David.Pulman@gsk.com
• Marc Dunoyer, President of Asia Pacific/Japan:
Marc.Dunoyer@gsk.com
• President of North American Pharmaceuticals, Board of
Directors: Chris.Viehbacher@gsk.com
• John Clarke, President of Consumer Healthcare:
John.Clarke@gsk.com
• Simon Bicknell, SVP, Company Secretary & Compliance
Officer: Simon.M.Bicknell@gsk.com
• Dan Phelan, Chief of Staff: Daniel.Phelan@gsk.com
• Claire Thomas, SVP, Human Resources:
Claire.x.Thomas@gsk.com

GSK WORLDWIDE LOCATIONS/ADDRESSES:
www.gsk.com/worldwide.htm

GlaxoSmithKline U.S. Corporate Headquarters
5 Moore Drive; Research Triangle Park, NC 27709
US corporate switchboard: +1 888-825-5249
US Customer Response Center: +1 888-825-5249

Glaxo Wellcome UK Ltd.
Stockley Park West, Uxbridge; Middlesex, UB11 1BT
ph: 020 8990 9000, 0800 221441
fax: 020 8990 4321, 020 8990 4328

SOURCE: www.gsk.com/worldwide/uk.htm,


Back to top



EMAIL BLOCKS (all emails found for this alert) • SEND THIS LETTER
• TO SEND: COPY/PASTE EMAIL BLOCKS INTO BCC: LINE OF YOUR EMAIL
• TYPE YOUR OWN EMAIL ADDRESS IN THE TO: LINE
• COPY/PASTE SAMPLE LETTER INTO SAME EMAIL.
• Change some words, sign with your name/full address and send!

AstraZeneca
david.brennan@astrazeneca.com, simon.lowth@astrazeneca.com, tony.zook@AstraZeneca.com, bruno.angelici@AstraZeneca.com, david.smith@AstraZeneca.com, jan.lundberg@AstraZeneca.com, lynn.tetrault@AstraZeneca.com, peter.bonfield@AstraZeneca.com

GlaxoSmithKline
Andrew.Witty@gsk.com, Julian.Heslop@gsk.com, Moncef.Slaoui@gsk.com, David.Pulman@gsk.com, Marc.Dunoyer@gsk.com, Chris.Viehbacher@gsk.com, John.Clarke@gsk.com, Simon.M.Bicknell@gsk.com, Daniel.Phelan@gsk.com, Claire.x.Thomas@gsk.com

***KINSHIP CIRCLE CANNOT GUARANTEE ALL EMAILS WILL WORK: During campaigns, recipients may change or disable their email addresses. Emails from government, corporate, or institute websites may be incorrect. We highly recommend you snail-mail or fax to those contacts without working or publicly available email addresses.

Back to top



SAMPLE LETTER • SEND THIS LETTER

Dear Sir/Madam,

I am concerned about the welfare of animals used in the development of your products. I understand that both AstraZeneca and GlaxoSmithKline severed ties with Huntingdon Life Sciences (HLS) after an investigation exposed routine animal abuse inside the research facility.

Your good faith in Huntingdon's promise to "clean up its act" led you to renew your contract. Sadly, abuse remains the norm at HLS. As recently as 2008, a published report about primate trafficking across South America and Asia described wild-caught monkeys squashed in cages for 30-hour treks to Huntingdon Life Sciences in Cambridgeshire.

Inside the primate unit, an undercover worker saw restrained monkeys forcibly overdosed on test materials via tube or inhalation. He recorded animals in filthy cages who "went crazy,” gnawing fingers and toes to the bone. One primate was tube fed after self-inflicted wounds left her face in shreds. The investigator counted 217 monkeys killed in just five studies for customers such as GlaxoSmithKline and AstraZeneca.

I respectfully ask you to re-join the global list of customers, suppliers and financiers who dropped HLS after learning about the lab's habitual abuse, falsification of test data, sloppy protocol, and employee misconduct.

Evidence from seven investigations over 12 years has exposed Huntingdon for multiple breaches of the U.S. Animal Welfare Act, the arrest of workers on animal cruelty charges, more than 520 infringements of Good Laboratory Practice in England, and a $50,000 payoff to the U.S. Agriculture Department for misstated records and animal welfare violations.

In 2005, two former HLS workers testified that animals were insufficiently anesthetized before invasive procedures, such as painful extraction of bone marrow from the chest bone. Workers transferred blood into the wrong tubes. One "would go in and out about five times with the same needle, not hitting the vein," the past employee maintained. "I saw co-workers grab [dogs] by the scruff, shout and swear at them, swing them by the scruff and slap them."

Many labs now meet testing criterion with non-animal methods that yield data more relevant to human health and safety. HLS, on the other hand, abuses animals for invalid and redundant experiments.

I urge you to permanently terminate all business with Huntingdon Life Sciences. Thank you for your valuable time and consideration.

Sincerely,

Back to top



Join our email list for ACTION CAMPAIGNS that address animal concerns worldwide. Our alerts let you speak influentially to key decision-makers who affect the outcome for animals.

Join our email list for an ANIMAL DISASTER AID network hat mobolizes volunteers, supplies and more for animal victims Get news about how to help animals stranded in disasters.

*First & Last Name
*Address
*Country
*Email    Phone
*City    *State    *Zip
Comments

*Text fields with *asterisk must be filled in to subscribe to Kinship Circle (for regional alerts and disaster aid zone...)

Enter the code exactly as you see it in the
image: (Cookies must be enabled)
Code Image - Please contact webmaster if you have problems seeing this image code  Load New Code

  

Back to top

spacer
spacerEDUCATIONAL LITERATURE
spacer
spacer
50+ TOPICS FOR YOUR ADVOCACY MATERIALS: 8.5 x 11" Fact Sheets with photos + timely info, stats, studies. Compelling literature to educate others on the animals' behalf. Download and print Kinship Circle Fact Sheets!

DONATE to help us fund printing and nationwide distribution of Kinship Circle educational literature.

DOWNLOAD FREE FACT SHEETS:
• Use entire high-resolution PDF of any KC Fact Sheet to support your animal advocacy work.
• Crop select photos and fact bites to make your own posters, flyers...

Fact Sheet  Fact Sheet  Fact Sheet 

Back to top

spacer
spacerDISCLAIMER
spacer
spacer
DISCLAIMER: The information in these materials is verified with the original source. Kinship Circle does not assume responsibility for the accuracy of the information or for the consequences of its use. Nothing on this website is intended to encourage illegal action in whatever country you are reading it in. Kinship Circle does not engage in, nor support, any form of harassment or unlawful activity. Nothing in this action alert serves to promote such conduct.

Kinship Circle cannot guarantee the validity of email addresses. During a campaign, recipients may change or disable their email addresses. Email addresses obtained from government or other official websites may be outdated or incorrect.

Back to top

Action Alerts  |  Email List  |  Fact Sheets  |  Store  |  About Us  |  Updates  |  Victories  |  Your Alerts  |  Links
spacerDisaster Aid  |  Donate  |  Volunteer  |  Columns & Articles  |  Ad Designs  |  Stanley  |  Mission  |  Home
spacer
GoodSearch